CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 52,500 shares at $6.65 ($349,125)
- 4 Open-market sale SVP Reg. & Quality sold 75,000 shares at an average $6.72 ($504,077)
- 4 Exercise or conversion Director acquired 15,853 shares (option exercise)
- 4 Exercise or conversion Director acquired 19,816 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,853 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,853 shares (option exercise)
- 4 Open-market sale Director sold 23,000 shares at $6.65 ($152,950)
- 4 Open-market sale Chief Financial Officer sold 73,000 shares at an average $6.42 ($468,822)
- 4 Open-market sale SVP Reg. & Quality sold 60,841 shares at $6.26 ($380,865)
- 4 Open-market sale Chief Medical Officer sold 8,631 shares at $6.69 ($57,722)
- 4 Open-market buy Chief Scientific Officer bought 150,011 shares at an average $5.15 ($773,199)
- 4 Open-market sale President and CEO sold 17,766 shares at an average $4.94 ($87,795)
- 4 Exercise or conversion Chief Scientific Officer acquired 13,500 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 4,737 shares at an average $4.94 ($23,409)
- 4 Open-market sale Chief Legal Officer sold 4,610 shares at an average $4.94 ($22,793)
- 4 Open-market sale SVP Reg. & Quality sold 4,686 shares at an average $4.94 ($23,151)
- 4 Open-market sale Chief Medical Officer sold 3,680 shares at an average $4.98 ($18,328)
Page 17 of 36 · 701 filings